338 related articles for article (PubMed ID: 30784671)
1. Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity.
Galán-Arriola C; Lobo M; Vílchez-Tschischke JP; López GJ; de Molina-Iracheta A; Pérez-Martínez C; Agüero J; Fernández-Jiménez R; Martín-García A; Oliver E; Villena-Gutierrez R; Pizarro G; Sánchez PL; Fuster V; Sánchez-González J; Ibanez B
J Am Coll Cardiol; 2019 Feb; 73(7):779-791. PubMed ID: 30784671
[TBL] [Abstract][Full Text] [Related]
2. Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease.
Ferreira de Souza T; Quinaglia A C Silva T; Osorio Costa F; Shah R; Neilan TG; Velloso L; Nadruz W; Brenelli F; Sposito AC; Matos-Souza JR; Cendes F; Coelho OR; Jerosch-Herold M; Coelho-Filho OR
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1045-1055. PubMed ID: 30092965
[TBL] [Abstract][Full Text] [Related]
3. Early Detection and Serial Monitoring of Anthracycline-Induced Cardiotoxicity Using T1-mapping Cardiac Magnetic Resonance Imaging: An Animal Study.
Hong YJ; Park HS; Park JK; Han K; Park CH; Kim TK; Yoo SJ; Lee JY; Kim PK; Hur J; Lee HJ; Kim YJ; Suh YJ; Paek MY; Choi BW
Sci Rep; 2017 Jun; 7(1):2663. PubMed ID: 28572614
[TBL] [Abstract][Full Text] [Related]
4. Myocardial Characterization Using Dual-Energy CT in Doxorubicin-Induced DCM: Comparison With CMR T1-Mapping and Histology in a Rabbit Model.
Hong YJ; Kim TK; Hong D; Park CH; Yoo SJ; Wickum ME; Hur J; Lee HJ; Kim YJ; Suh YJ; Greiser A; Paek MY; Choi BW
JACC Cardiovasc Imaging; 2016 Jul; 9(7):836-845. PubMed ID: 27236517
[TBL] [Abstract][Full Text] [Related]
5. Multi-parameter cardiac magnetic resonance imaging detects anthracycline-induced cardiotoxicity in rabbits model.
Hu Y; Ma P; Chen L; Liu J; Shang Y; Jian W
Heliyon; 2023 Nov; 9(11):e21845. PubMed ID: 38058655
[TBL] [Abstract][Full Text] [Related]
6. Identifying early stages of doxorubicin-induced cardiotoxicity in rat model by 7.0 tesla cardiovascular magnetic resonance combining hematological and pathological parameters.
Wang S; Zhu T; Wang C; Wang L; He B; Gao F
Magn Reson Imaging; 2022 Jul; 90():17-25. PubMed ID: 35122985
[TBL] [Abstract][Full Text] [Related]
7. Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes.
Park HS; Hong YJ; Han K; Kim PK; An E; Lee JY; Park CH; Lee HJ; Hur J; Kim YJ; Choi BW
J Cardiovasc Magn Reson; 2021 Jun; 23(1):76. PubMed ID: 34134713
[TBL] [Abstract][Full Text] [Related]
8. Cardiac MRI Myocardial Functional and Tissue Characterization Detects Early Cardiac Dysfunction in a Mouse Model of Chemotherapy-Induced Cardiotoxicity.
Naresh NK; Misener S; Zhang Z; Yang C; Ruh A; Bertolino N; Epstein FH; Collins JD; Markl M; Procissi D; Carr JC; Allen BA
NMR Biomed; 2020 Sep; 33(9):e4327. PubMed ID: 32567177
[TBL] [Abstract][Full Text] [Related]
9. Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity.
Galán-Arriola C; Villena-Gutiérrez R; Higuero-Verdejo MI; Díaz-Rengifo IA; Pizarro G; López GJ; Molina-Iracheta A; Pérez-Martínez C; García RD; González-Calle D; Lobo M; Sánchez PL; Oliver E; Córdoba R; Fuster V; Sánchez-González J; Ibanez B
Cardiovasc Res; 2021 Mar; 117(4):1132-1143. PubMed ID: 32597960
[TBL] [Abstract][Full Text] [Related]
10. Early detection of myocardial changes with and without dexrazoxane using serial magnetic resonance imaging in a pre-clinical mouse model.
Noel CV; Rainusso N; Robertson M; Romero J; Masand P; Coarfa C; Pautler R
Cardiooncology; 2021 Jun; 7(1):23. PubMed ID: 34134789
[TBL] [Abstract][Full Text] [Related]
11. Coronary microcirculation damage in anthracycline cardiotoxicity.
Galán-Arriola C; Vílchez-Tschischke JP; Lobo M; López GJ; de Molina-Iracheta A; Pérez-Martínez C; Villena-Gutiérrez R; Macías Á; Díaz-Rengifo IA; Oliver E; Fuster V; Sánchez-González J; Ibanez B
Cardiovasc Res; 2022 Jan; 118(2):531-541. PubMed ID: 33605403
[TBL] [Abstract][Full Text] [Related]
12. Early myocardial oedema can predict subsequent cardiomyopathy in high-dose anthracycline therapy.
Muehlberg F; Kornfeld M; Zange L; Ghani S; Reichardt A; Reichardt P; Schulz-Menger J
ESC Heart Fail; 2023 Feb; 10(1):616-627. PubMed ID: 36404640
[TBL] [Abstract][Full Text] [Related]
13. Assessment of early anthracycline-induced cardiotoxicity and liver injury with T2 and T2* mapping in rabbit models.
Feng XL; Qi WY; Xiao ZY; Zheng X; Zhang XY; Liu T; Kou XY; Chen J
Eur Radiol; 2024 Jan; 34(1):226-235. PubMed ID: 37552260
[TBL] [Abstract][Full Text] [Related]
14. Prospective multiparametric CMR characterization and MicroRNA profiling of anthracycline cardiotoxicity: A pilot translational study.
Harries I; Biglino G; Ford K; Nelson M; Rego G; Srivastava P; Williams M; Berlot B; De Garate E; Baritussio A; Liang K; Baquedano M; Chavda N; Lawton C; Shearn A; Otton S; Lowry L; Nightingale AK; Carlos Plana J; Marks D; Emmanueli C; Bucciarelli-Ducci C
Int J Cardiol Heart Vasc; 2022 Dec; 43():101134. PubMed ID: 36389268
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of anthracycline-induced myocardial injury using serial cardiac magnetic resonance: An animal study.
Wang R; Zhou Z; Schoepf UJ; Varga-Szemes A; Strigenz A; Wang H; Liu Y; Xu L
Int J Cardiol; 2021 Apr; 328():111-116. PubMed ID: 33359332
[TBL] [Abstract][Full Text] [Related]
16. Screening for
Chakouri N; Farah C; Matecki S; Amedro P; Vincenti M; Saumet L; Vergely L; Sirvent N; Lacampagne A; Cazorla O
Theranostics; 2020; 10(18):8130-8142. PubMed ID: 32724462
[TBL] [Abstract][Full Text] [Related]
17. Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.
Skubitz KM; Blaes AH; Konety SH; Francis GS
Cancer Chemother Pharmacol; 2017 Oct; 80(4):787-798. PubMed ID: 28856562
[TBL] [Abstract][Full Text] [Related]
18. Nicorandil Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats, as Evaluated by 7 T Cardiovascular Magnetic Resonance Imaging.
Wan Y; He B; Zhu D; Wang L; Huang R; Wang S; Wang C; Zhang M; Ma L; Gao F
Cardiovasc Drugs Ther; 2023 Feb; 37(1):39-51. PubMed ID: 34595611
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging.
Farhad H; Staziaki PV; Addison D; Coelho-Filho OR; Shah RV; Mitchell RN; Szilveszter B; Abbasi SA; Kwong RY; Scherrer-Crosbie M; Hoffmann U; Jerosch-Herold M; Neilan TG
Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27923796
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular magnetic resonance characterization of myocardial tissue injury in a miniature swine model of cancer therapy-related cardiovascular toxicity.
Nakata K; Kucukseymen S; Cai X; Yankama T; Rodriguez J; Sai E; Pierce P; Ngo L; Nakamori S; Tung N; Manning WJ; Nezafat R
J Cardiovasc Magn Reson; 2024 Mar; 26(1):101033. PubMed ID: 38460840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
